Nanjing Minimally Invasive Medical Technology Co., Ltd. (hereinafter referred to as "Nanjing minimally invasive") recently disclosed in the SFC website prospectus, the company intends to public offering on the Shanghai Stock Exchange does not exceed 3334 million shares, after the release of the company's total share capital of not more than 133 million shares The Sponsor institutions for CITIC investment securities.
 
Prospectus shows, Nanjing minimally invasive IPO to raise about 400 million yuan of funds, of which 0.9 billion will be used to supplement working capital, 2.31 billion plan to invest in production base expansion, 0.79 billion for marketing network and brand building two Class items.